Yuvraj Singh joins Healthians founder’s stealth healthtech startup UN:BLOC as investor and founder
Cricketer Yuvraj Singh has joined UN:BLOC, a stealth healthtech startup founded by Deepak Sahni, the former CEO of at-home diagnostics provider Healthians. Singh will serve as both an investor and a founder, marking his second collaboration with Sahni after his 2015 investment in Healthians. UN:BLOC is developing an AI-powered platform for chronic disease care, aiming to shift the focus from lifelong management to root-cause treatment.
Editor, Lazyfounder

TABLE OF CONTENTS
KEY HIGHLIGHTS
- Cricketer Yuvraj Singh has joined healthtech startup UN:BLOC as a founder and investor.
- UN:BLOC was founded by Deepak Sahni, who previously founded at-home diagnostics provider Healthians.
- The startup is operating in stealth and building an AI-powered platform for end-to-end chronic disease care.
- UN:BLOC aims to treat the root causes of chronic illnesses, reducing the need for lifelong medication.
- Singh’s investment is part of a pre-launch funding round, with additional investors expected to join soon.
Who is behind UN:BLOC
UN:BLOC was founded by Deepak Sahni, who previously launched Healthians in 2014, a startup offering doorstep diagnostic testing across India. Sahni stepped down from his day-to-day role at Healthians in January to focus on new ventures, citing a desire to address "deeper problems in healthcare."
The startup has attracted cricketer Yuvraj Singh as both an investor and a co-founder. Singh previously invested in Healthians in 2015 through his early-stage fund, YouWeCan Ventures, which has backed startups like Wellversed and JetSetGo.
What UN:BLOC is building
UN:BLOC is operating in stealth mode and has not disclosed details about its platform’s offerings, technology, or launch timeline. According to sources quoted by Inc42, the startup is developing an AI-powered platform focused on chronic disease care, aiming to provide an end-to-end model that includes early diagnosis, treatment, and long-term management.
The startup’s approach emphasizes treating the root causes of chronic illnesses to reduce dependence on lifelong medication. Sahni stated that UN:BLOC aims to "change how a patient is seen, not as someone to be managed for life, but as someone who can be understood at the root."
Funding and investor interest
Singh’s investment is part of UN:BLOC’s pre-launch funding round, though the amount has not been disclosed. The startup is in discussions with a group of founders, healthcare leaders, and business executives to raise additional capital, with several expected to join its cap table in the coming weeks.
The development reflects broader investor interest in AI-driven healthtech platforms, particularly those addressing chronic disease management. Recent funding rounds in the sector include Mykare’s $1 Mn raise and SuperLiving’s $7 Mn Series A.
Why this matters for healthtech
UN:BLOC’s focus on chronic disease care aligns with a growing trend in healthtech, where startups are leveraging AI and data to offer preventive and personalized healthcare solutions. Competitors like CENT and Biopeak are also using AI to detect diseases early and generate personalized insights based on biomarkers and lifestyle data.
The Indian healthtech market is projected to reach $37 Bn by 2030, with chronic disease management emerging as a key segment. The involvement of experienced founders and high-profile investors like Singh could accelerate innovation and funding in this space.
What this means
Lazyfounder analysis — our interpretation, not reported fact.
UN:BLOC’s entry into chronic disease care highlights a strategic shift in healthtech—moving beyond diagnostics to address root causes and long-term management. For founders, this signals an opportunity to explore AI-driven, preventive healthcare models, especially in segments where traditional approaches have focused on symptom management rather than cure. The involvement of a serial entrepreneur like Sahni and a well-known investor like Singh may also serve as a validation for the sector, potentially attracting more capital and talent to healthtech startups tackling complex, underserved problems.
Key takeaways
- UN:BLOC’s focus on chronic disease management signals a shift in healthtech toward preventive and root-cause-driven care, a segment gaining traction among investors.
- The involvement of a high-profile founder like Sahni and investor like Singh may attract further capital and talent to the venture.
- For founders, this move underscores the growing investor interest in AI-driven healthtech platforms, particularly those addressing chronic conditions.
- The stealth approach suggests UN:BLOC is prioritizing product development before scaling, a strategy relevant for startups in regulated or complex sectors like healthcare.
Sources
- inc42.com · 2026-08-03
Yuvraj Singh Backs Healthians Founder’s New Venture UN:BLOC, Joins Founding Team
This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.
About the author
Editor, Lazyfounder
Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.
More stories by Tarun MottliaGet the LazyFounder Brief
Startup, funding and AI news in a five-minute read. Join the early-access list.


